Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus
H. Nagafuchi1, Y. Shimoyama, J. Kashiwakura, M. Takeno, T. Sakane, N. Suzuki
Departments of Immunology and Medicine, and 1Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan
ABSTRACT
Objective
B7 (CD80/CD86) molecules are over-expressed in patients with SLE. However, it is not clear whether CD80/CD86 molecules are involved in the pathogenic autoantibody production specifically or in the polyclonal antibody
production in human SLE. The present study was carried out to characterize B7 molecules on B cells in
autoantibody production.
Methods
Expression of costimulatory molecules was analyzed by RT-PCR and two-color immunofluorescence staining.
Purified B cells were co-cultured with T cells in the presence of anti-costimulatory molecule antibody.
Results
Excessive expression of CD86 and CD80 molecules was evident on freshly isolated B cells in patients with SLE.
Normal B cells did not express CD86 molecules spontaneously and expressed it after co-culture with activated T cells. CD86 expression on normal and SLE B cells induced by the activated T cells was inhibited by the addition of anti-CD40L into the cell culture. Furthermore, CD40L expression on T cells upon activation was enhanced in SLE patients.
Anti-DNA antibody production by SLE B cells in the presence of activated T cells was markedly inhibited by anti-CD86, but not anti-CD80. Anti-CD86 treatment inhibited polyclonal Ig and anti-SS-A antibody production of SLE
B cells, suggesting the preferential involvement of CD86 in polyclonal antibody production.
Conclusion
SLE T cells express CD40L excessively, and the CD40/CD40L pathway is involved in the CD86 over-expression of SLE B cells; thus T cell abnormality is at least partially involved in B cell hyperactivity. Enhanced CD86 expression
of B cells by CD40L is essential for polyclonal antibody production.
Key words
CD40L, B7, SLE, anti-DNA autoantibody.
Please address correspondence and reprint requests to: Dr. Noboru Suzuki, Departments of Immunology and Medicine, St. Marianna University School of Medicine,
2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-8511, Japan.
E-mail: n3suzuki@marianna-u.ac.jp
Clin Exp Rheumatol 2003; 21: 71-77.
© Copyright Clinical and Experimental
Rheumatology 2003.